Andus, Ana Lou S.

HRN: 26-84-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2025
CEFTRIAXONE 1G (VIAL)
03/20/2025
04/09/2025
IV
2g
Q24
CMBO
Waiting Final Action 
03/20/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/20/2025
04/10/2025
IV
500MG
Q8
CMBO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: